Clinical Trial Update: Autologous Blood Monocyte Vesicles for the Treatment of Sudden Deafness [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) clinical trial evaluating autologous blood monocyte vesicles for treating sudden sensorineural hearing loss; the study is not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sudden Sensorineural Hearing Loss

Drugs mentioned

• Autologous Blood Monocyte Vesicles

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Sudden Deafness, Sensorineural Hearing Loss | EARLY_Phase 1 | Status: NOT_YET_RECRUITING